Sanofi (SNY) income statement
SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30
$47.12−0.41 (-0.86%)
Close on Nov 18, 2026Market cap $114.92BP/E 13.4Yield –
Sanofi income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- 10.5%
Financial strength
- Current ratio
- 0.99
- Debt to equity
- 0.31
- Debt to assets
- 16.8%
- Cash to current liabilities
- 19.9%
Valuation
- P/E ratio
- 13.4
- Price to sales
- –
- Price to book
- 1.50
- Dividend yield
- –
See a number that looks wrong?